Hope Valley, RI, United States of America

Diane M Lang

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Diane M. Lang in the Field of Anti-NGF Antibodies**

Introduction

Diane M. Lang, an accomplished inventor based in Hope Valley, Rhode Island, holds three patents that reflect her significant contributions to the biotechnology industry. Her work primarily focuses on the development of innovative antibodies that have the potential to transform therapeutic approaches for disorders linked to neurotrophic factors.

Latest Patents

Diane's latest patents include groundbreaking discoveries in the field of anti-NGF (Nerve Growth Factor) antibodies. One notable patent, titled "Caninized anti-NGF antibodies and their use," discloses a set of NGF-binding proteins, specifically highlighting chimeric, CDR (Complementarity Determining Region) grafted, and canonized antibodies. These innovative antibodies are designed for detecting NGF and inhibiting its activity, particularly in mammalian subjects afflicted with conditions where NGF activity proves detrimental. Another patent, simply titled "Anti-NGF antibodies and their use," emphasizes similar methodologies and applications, showcasing her important contributions to advancing medical treatments.

Career Highlights

Currently, Diane M. Lang is associated with Zoetis Belgium S.a., a leader in the animal health sector, where her research continues to influence the development of veterinary therapeutics. Her expertise and innovative approach have positioned her as a key figure in her field, focusing on the therapeutic potential of her patented antibodies.

Collaborations

Diane collaborates with esteemed colleagues, including Susan E. Lacy and Jeffrey A. Barbon. Together, they work towards advancing research efforts in understanding and manipulating NGF activity, supporting the broader goal of improving health outcomes for both humans and animals.

Conclusion

Diane M. Lang's innovative work in the sphere of anti-NGF antibodies underscores her importance as an inventor in the biotechnology field. Her patented inventions not only demonstrate her scientific acumen but also hold the promise of advancing therapeutic interventions for disorders mediated by NGF activity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…